This landmark study is the first-ever side-by-side comparison of 171 antibodies against Ebola virus.
A one-two punch of powerful antibodies may be the best way to stop Ebola virus, reports an international team of scientists in the journal Cell. Their findings suggest new therapies should disable Ebola virus’s infection machinery and spark the patient’s immune system to call in reinforcements.
“This study presents results from an unprecedented international collaboration and demonstrates how 43 previously competing labs can together accelerate therapeutics and vaccine design,” says Erica Ollmann Saphire, PhD, professor at Scripps Research and director of the Viral Hemorrhagic Fever Immunotherapeutic Consortium (VIC).
From 2013–2016, West Africa faced the deadliest Ebola outbreak the world has ever seen. By the time the outbreak was declared over, 11,325 people had died. The VIC is an international group of the world’s leading virologists, immunologists, systems biologists and structural biologists working to stop an outbreak on that scale from ever striking again.
The VIC researchers aim to understand which Ebola-fighting antibodies are best—and why. The hope is that the most effective antibodies can be combined in a therapeutic “cocktail.” Unlike an Ebola vaccine, these cocktails could be given to those already infected, which is important for stopping a disease that tends to emerge unexpectedly in remote locations.
Ollmann Saphire and her colleagues in the VIC have published more than 40 studies in just the last five years. This landmark study is the first-ever side-by-side comparison of 171 antibodies against Ebola virus and other related viruses, known as filoviruses. All antibodies in the panel were donated by different labs around the world, and many had not been previously characterized in such extensive detail.
“Through the VIC, we could test a larger pool of antibodies in parallel, which increased the potential to detect statistically significant relationships between antibody features and protection,” says Saphire. “We used this global pool of antibodies to evaluate, and streamline, the research pipeline itself.”
In addition to identifying links between antibody target locations and activity, VIC researchers tested this huge pool of antibodies to reveal which antibodies “neutralized” the virus, why neutralization assays so often disagree, and whether or not neutralization in test tubes adequately predicted how well these antibodies would protect live animals from Ebola virus infection. Unexpectedly, neutralization alone was not always associated with the protective ability of an antibody.
Notably, the scientists found nine antibodies that protected mice from infection without neutralizing the virus in test tubes. These antibodies likely fight infection by interacting with an infected person’s immune system, helping orchestrate a better immune response to the virus.
This “immune effector” activity is featured in the team’s companion study published simultaneously in Cell Host & Microbe. “The ability to evoke an immune response will likely represent a new avenue of study for therapeutic antibodies for Ebola virus infection,” says Sharon Schendel, project manager for the VIC and science writer in the Saphire lab.
From the large body of results, VIC member and Scripps Research faculty member Kristian Andersen, PhD, and his graduate student Karthik Gangavarapu developed a network describing how each antibody feature correlates to protection, which can serve as a guide to predict whether newly identified antibodies will have therapeutic value. Saphire says the next steps for the VIC are to further test promising antibody cocktails in non-human primates. The team will also pursue engineering of antibodies that carry signature features to better drive immune system response.
Learn more: Ebola virus experts discover powerful, new approach for future therapeutics
The Latest on: Ebola
[google_news title=”” keyword=”Ebola” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Ebola
- Improving public health communication in African epidemics: Lessons learned and future directionson April 26, 2024 at 10:20 am
Zika and other public health emergencies, effective communication of public health messages is crucial to control the spread of disease, maintain public trust, and encourage compliance with health ...
- Plant-based products can keep us all healthy | PennLive letterson April 25, 2024 at 5:01 pm
The unprecedented transmission of the H5N1 virus to cows has drawn public health concerns because cows are mammals, just like humans ...
- Federal bill would track deadly virus sales, try to prevent repeat of illegal Reedley labon April 25, 2024 at 6:19 am
The bill would establish a new “Public Health and Biosecurity Team” as a single point of contact for state and local agencies dealing with biological laboratories.
- Pentagon watchdog will audit $50M in US funding to Chinese research labs revealed by Sen. Ernston April 24, 2024 at 1:51 pm
The Pentagon’s watchdog agency will audit more than $50 million in grants the US provided to Chinese pandemic pathogens research institutions between 2014 and 2023, The Post has learned, following a ...
- Remember ‘Contagion?’ A New Treatment For Nipah Virus Could Be A Game Changeron April 24, 2024 at 5:00 am
Nipah virus has no licensed treatment or vaccine. As reported in the study, scientists from multiple institutions, including the Uniformed Services University, University of Texas Medical Branch, ...
- How Ugandan Tobacco Farming Inadvertently Threatens Spread of Bat-Borne Viruseson April 23, 2024 at 3:45 am
By cutting trees in response to international demand for tobacco, farmers induced wildlife to start eating virus-laden bat guano ...
- This Kenya Cave, Believed To Be Source Of Ebola, Could Cause Next Pandemic: WHO Issues Warning About Marburg Virus Outbreakon April 22, 2024 at 10:29 pm
The world's deadliest cave Kitum, located in Mount Elgon National Park in Kenya, could cause the next pandemic. Read on to know more.
- Believed to be the source of Ebola, this Kenya cave could be ground zero for the next pandemicon April 22, 2024 at 6:54 pm
Located in Kenya's Mount Elgon National Park, the Kitum Cave was reportedly the origin point for the Ebola and Marburg viruses, of which the latter has been termed as 'epidemic-prone' by the World ...
- Joel Breman, Who Helped Stop an Ebola Outbreak in Africa, Dies at 87on April 22, 2024 at 4:11 pm
Part of a team flown in to fight the deadly virus in 1976, Dr. Breman also worked to stamp out tropical diseases like smallpox, malaria and Guinea worm.
via Bing News